Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $4.6 million.

  • Xtant Medical Holdings' Cash from Operations rose 36845.17% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 15811.07%. This contributed to the annual value of -$11.9 million for FY2024, which is 2502.36% down from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Cash from Operations is $4.6 million, which was up 36845.17% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Cash from Operations peaked at $4.6 million during Q3 2025, and registered a low of -$5.8 million during Q1 2024.
  • Moreover, its 5-year median value for Cash from Operations was -$1.0 million (2022), whereas its average is -$1.0 million.
  • In the last 5 years, Xtant Medical Holdings' Cash from Operations soared by 95586.85% in 2021 and then tumbled by 1690666.67% in 2023.
  • Over the past 5 years, Xtant Medical Holdings' Cash from Operations (Quarter) stood at $423000.0 in 2021, then plummeted by 640.9% to -$2.3 million in 2022, then skyrocketed by 60.01% to -$915000.0 in 2023, then surged by 172.68% to $665000.0 in 2024, then skyrocketed by 593.53% to $4.6 million in 2025.
  • Its Cash from Operations was $4.6 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.3 million in Q1 2025.